Answers are grounded in this paper and cite their sources.
Kidney transplant recipients with the CYP3A5 *1 allele required a higher daily tacrolimus dose compared with those with the CYP3A5 *3/*3 genotype to maintain both the target trough level and AUC0-12, suggesting that this polymorphism is useful for determining the appropriate dose of tacrolimus.
No takes yet. Share an insight, caveat, or question.
Tsuchiya et al. (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: